Introduction
Highly active antiretroviral therapy (HAART) has significantly reduced mortality due to HIV infection; however, there is concern that this therapy can cause dyslipidemia and increase the risk for coronary disease. Additionally, given their immunocompromised condition, these patients may be at increased risk for postoperative infections and complications. We evaluated HIV (+) patients undergoing cardiac surgery at a single center to determine the rate of complications, infections, and need for revascularization.
Methods
A retrospective review of 10,747 consecutive cardiac surgery patients at Inova Heart and Vascular Institute revealed 12 patients who were found to be HIV (+). Data was reviewed from the STS database and supplemented with chart review of these 12 patients for CD4 count, viral load, opportunistic infections, antiretroviral use, and repeat revascularization. Comparisons were made with the HIV (+) group and a subgroup of patients with age less than 55 ( n =2775), in areas of length of stay, infection, stroke, operative death, prolonged ventilator use, readmission within 30 days, and renal failure.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
